Sign in

Private company

CROSS COUNTRY HEALTHCARE INC

CROSS COUNTRY HEALTHCARE INC is an American help supply services company based in Boca Raton, active since 1999.2

Last updated Oct 21, 2026.

Overview

  • IndustryServices-Help Supply Services2
  • HeadquartersBoca Raton, United States2
  • Incorporated inDE3
  • Business address5201 Congress Avenue, Suite 160, Boca Raton, Fl3
  • Filer categoryAccelerated filer3
  • Legal formCorporation2
  • LEI54930037L0NBIPZ5S6632
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 30459792

See how the biggest companies compare on our leaderboards

Cross Country Healthcare, Inc. (Nasdaq: CCRN) is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services, backed by nearly 40 years of healthcare labor expertise, to help health systems optimize and sustain their entire labor ecosystem.5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-8.0%Operating margin6
-9.0%Net margin6
-21.6%Revenue growth, 20256
-29.4%Return on equity6
$40.1MFree cash flow6

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Selling, general and admin19¢$200.7M
  • Other costs80¢$842.3M
  • Income tax1¢$11.3M

Out of $1.1B in revenue.6 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending17¢$8.2M
  • Share buybacks14¢$6.8M
  • Kept or used elsewhere69¢$33.3M

Out of $48.3M of cash from operations.6

Financial statements

Revenue789106$1.1B in 2025+28% since 2019
0$1.0B$2.0B$3.0B2019: $822.2M$822.2M20192020: $836.4M$836.4M2020+2%2021: $1.7B$1.7B2021+100%2022: $2.8B$2.8B2022+67%2023: $2.0B$2.0B2023−28%2024: $1.3B$1.3B2024−33%2025: $1.1B$1.1B2025−22%
Operating income789106-$84.4M in 2025+437% since 2019
-$100.0M0$100.0M$200.0M$300.0M2019: -$15.7M-$15.7M20192020: -$9.2M-$9.2M2020−42%2021: $139.3M$139.3M20212022: $269.9M$269.9M2022+94%2023: $112.7M$112.7M2023−58%2024: -$16.9M-$16.9M20242025: -$84.4M-$84.4M2025+401%
Net income7116-$94.9M in 2025+64% since 2019
-$100.0M0$100.0M$200.0M2019: -$57.7M-$57.7M20192020: -$13.0M-$13.0M2020−78%2021: $132.0M$132.0M20212022: $188.5M$188.5M2022+43%2023: $72.6M$72.6M2023−61%2024: -$14.6M-$14.6M20242025: -$94.9M-$94.9M2025+552%
Fiscal year2019202020212022202320242025
Revenue$822.2M7$836.4M8$1.7B9$2.8B10$2.0B6$1.3B6$1.1B6
Selling, general and admin$182.0M7$173.8M8$216.4M9$324.2M10$300.3M6$233.4M6$200.7M6
Operating expenses$1.5B9$2.5B10$1.9B6$1.4B6$1.1B6
Operating income-$15.7M7-$9.2M8$139.3M9$269.9M10$112.7M6-$16.9M6-$84.4M6
Interest$5.3M7$2.9M8$6.9M9$14.4M9$8.1M9
Income before tax$133.2M9$253.1M10$102.9M6-$16.4M6-$83.5M6
Income tax$31.7M7-$188.0K8$1.2M9$67.1M10$30.3M6-$1.8M6$11.3M6
Net income-$57.7M7-$13.0M11$132.0M11$188.5M11$72.6M6-$14.6M6-$94.9M6
Earnings per share-$1.617-$0.368$3.609$5.0210$2.076-$0.446-$2.936
Earnings per share (diluted)-$1.617-$0.368$3.539$4.9510$2.056-$0.446-$2.936
Shares (weighted, basic)36.7M shares937.0M shares1035.2M shares633.4M shares632.4M shares6
Shares (weighted, diluted)37.4M shares937.5M shares1035.5M shares633.4M shares632.4M shares6

Compare CROSS COUNTRY HEALTHCARE INC with another company

Corporate structure

CROSS COUNTRY HEALTHCARE INC sits at the top of its group. 13 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of CROSS COUNTRY HEALTHCARE INC

  • Boston Partners Filed SCHEDULE 13G on CROSS COUNTRY HEALTHCARE INC, latest May 14, 2026
  • DIMENSIONAL FUND ADVISORS LP Filed SCHEDULE 13G/A on CROSS COUNTRY HEALTHCARE INC, latest Apr 9, 2026 (3 filings since Feb 8, 2022)
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on CROSS COUNTRY HEALTHCARE INC, latest Mar 26, 2026 (5 filings since Feb 9, 2022)
  • AllianceBernstein Filed SCHEDULE 13G/A on CROSS COUNTRY HEALTHCARE INC, latest Feb 17, 2026 (3 filings since May 14, 2025)
  • Magnetar Financial LLC Filed SCHEDULE 13D/A on CROSS COUNTRY HEALTHCARE INC, latest Dec 10, 2025 (5 filings since Dec 20, 2024)
  • Goldman Sachs Filed SCHEDULE 13G/A on CROSS COUNTRY HEALTHCARE INC, latest Nov 12, 2025 (3 filings since May 9, 2025)
  • BlackRock Filed SCHEDULE 13G/A on CROSS COUNTRY HEALTHCARE INC, latest Jul 16, 2025 (7 filings since Jan 28, 2022)
  • PRINCIPAL GLOBAL INVESTORS Filed SC 13G/A on CROSS COUNTRY HEALTHCARE INC, latest Nov 13, 2024 (2 filings since Feb 13, 2024)
  • WASATCH ADVISORS LP Filed SC 13G/A on CROSS COUNTRY HEALTHCARE INC, latest Nov 13, 2024 (2 filings since Feb 9, 2024)
  • SYSTEMATIC FINANCIAL MANAGEMENT LP Filed SC 13G/A on CROSS COUNTRY HEALTHCARE INC, latest Feb 13, 2024 (3 filings since Feb 10, 2022)
  • Wellington Management Company Filed SC 13G/A on CROSS COUNTRY HEALTHCARE INC, latest Feb 6, 2023 (2 filings since Feb 4, 2022)
  • Simcoe Capital Management, LLC Filed SC 13D/A on CROSS COUNTRY HEALTHCARE INC, latest Oct 28, 2022 (2 filings since Sep 1, 2022)
  • CROSS COUNTRY HEALTHCARE INC Boca Raton, Florida, United States
    • Assignment America, LLC Subsidiary · Delaware, United States
    • Cejka Search, LLC Subsidiary · Delaware, United States
    • Credent Verification and Licensing Services, LLC Subsidiary · Delaware, United States
    • Cross Country DAS, Inc. Subsidiary · Delaware, United States
    • Cross Country Infotech, Pvt. Ltd. Subsidiary · India
    • Cross Country Staffing, Inc. Subsidiary · Delaware, United States
    • Cross Country Tech, LLC Subsidiary · Delaware, United States
    • Intellify Talent Solutions, LLC Subsidiary · Delaware, United States
    • Medical Doctor Associates, LLC Subsidiary · Delaware, United States
    • New Mediscan II, LLC Subsidiary · California, United States
    • OWS, LLC Subsidiary · Delaware, United States
    • Travel Staff, LLC Subsidiary · Delaware, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What CROSS COUNTRY HEALTHCARE INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$53.8M6 Dec 31, 2025$48.1M6 Dec 31, 2024+11.8%
Accumulated depreciation$26.0M6 Dec 31, 2025$19.3M6 Dec 31, 2024+34.9%
Property and equipment, net$27.8M6 Dec 31, 2025$28.9M6 Dec 31, 2024−3.7%
Operating-lease assets (leased space)$2.2M6 Dec 31, 2025$2.5M6 Dec 31, 2024−10.6%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$108.7M6 Dec 31, 2025$81.6M6 Dec 31, 2024+33.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$63.8M6 Dec 31, 2025$135.1M6 Dec 31, 2024−52.8%
Intangible assets, net (excluding goodwill)$27.6M6 Dec 31, 2025$42.2M6 Dec 31, 2024−34.5%
Trademarks and trade names (indefinite-lived)$06 Dec 31, 2025$5.9M6 Dec 31, 2024−100.0%
Finite-lived intangibles, gross$75.1M6 Dec 31, 2025$89.1M6 Dec 31, 2024−15.7%
Accumulated amortization$47.4M6 Dec 31, 2025$52.8M6 Dec 31, 2024−10.1%
Finite-lived intangibles, net$27.6M6 Dec 31, 2025$36.3M6 Dec 31, 2024−23.8%

Properties, in its own words

As of December 31, 2025, we actively leased office space in 10 facilities located in 4 states within the United States. We also lease office space in a facility located in Pune, India. See our lease obligations as of December 31, 2025 in Note 9 - Leases to our consolidated financial statements. We continuously evaluate facility needs based on the extent of our service offerings, the rate of customer growth or decline, the geographic distribution of our customer base, changing market conditions, and our long-term goals. As of December 31, 2025, our material leased properties are described below:

In December 2025, we relocated our corporate headquarters within Boca Raton, Florida. Our new headquarters has approximately 26,000 square feet of office space under lease through December 2026. This space is occupied by our corporate executive staff, legal, finance, risk management, internal audit, and information technology teams. Our Nurse and Allied executive staff and operations personnel, as well as shared support functions of human resources, payroll and billing, sales, and marketing also occupy this space.

The rest of Item 2

Our facility located in Pune, India has approximately 38,000 square feet of office space under lease through April 2029. This space houses certain software development and information technology support, as well as certain sourcing, finance, and shared support services.

Item 2 of the 10-K filed Mar 9, 2026.5

Leadership

Who has led CROSS COUNTRY HEALTHCARE INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Joseph Boshart2006–2013
  2. William J. Grubbs2014–2019
  3. John Anthony Martins2022–now

President

  1. Carol D. Westfall2006–2008
  2. Joseph Boshart2006–2013
  3. Anthony Sims2007
  4. Lori Ann Schutte2009–2010
  5. William J. Grubbs2013–2019
  6. Frederick Dennis Ducham2015–2018
  7. Timothy L. Fischer2016–2019
  8. Matthew R. Price2017
  9. Marisa Leigh Zaharoff2018–2020
  10. Buffy S. White2018
  11. Karen Mote2019–2022
  12. John Anthony Martins2022
  13. Marc S. Krug2022–now

Chief financial officer

  1. Emil Hensil2006–2013
  2. Christopher R. Pizzi2016–2020

Chief operating officer

  1. William J. Grubbs2013
  2. Amiee Lin Hawkins2026–now
2010201520202025
Board members and other officers (43)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Mr. Purgay is the Chief Marketing Officer of the Issuer.Gerald P. Purgay named Dec 30, 2021 to Jan 10, 202272
  • Mr. Clark is the President and Chief Executive Officer.Kevin C. Clark named Dec 30, 2021 to Jan 10, 202272
  • Mr. Spiegel is the President, Education of the Issuer.Mihal P. Spiegel named Dec 30, 2021 to Jan 10, 202272
  • Mr. Jung is the President of the Cross Country Workforce Solutions Group of the Issuer.Pamela K. Jung named Dec 30, 2021 to Jan 10, 202272
  • Mr. Burns is the Executive Vice President and Chief Financial Officer of the Issuer.William J. Burns named Dec 30, 2021 to Jan 10, 202272
  • DirectorDarrell S. Freeman, Sr. named Dec 30, 2021 to Jan 10, 202272

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Assignment America, LLC Delaware4
  • Cejka Search, LLC Delaware4
  • Credent Verification and Licensing Services, LLC Delaware4
  • Cross Country DAS, Inc. Delaware4
  • Cross Country Infotech, Pvt. Ltd. India4
  • Cross Country Staffing, Inc. Delaware4
  • Cross Country Tech, LLC Delaware4
  • Intellify Talent Solutions, LLC Delaware4
  • Medical Doctor Associates, LLC Delaware4
  • New Mediscan II, LLC California4
  • OWS, LLC Delaware4
  • Travel Staff, LLC Delaware4

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • CROSS COUNTRY INCJul 11, 2001 to Apr 16, 20033

Timeline

  1. Jul 28, 20268-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer73
  2. Jul 17, 20268-K Shareholder vote74
  3. Jul 6, 20268-K Other events75
  4. Jun 23, 20268-K Other events76
  5. May 7, 20268-K Entered a material agreement; Regulation FD disclosure; Other events77
  6. May 7, 20268-K Results of operations; Regulation FD disclosure78
  7. Apr 17, 20268-K Regulation FD disclosure79
  8. Mar 30, 20268-K Executive or director change80
  9. Mar 17, 20268-K Executive or director change81
  10. Mar 10, 20268-K Executive or director change82
  11. Mar 4, 20268-K Results of operations; Regulation FD disclosure83
  12. Feb 23, 20268-K Regulation FD disclosure84
  13. Apr 4, 2022New chief executive John Anthony Martins becomes CEO16
  14. Apr 2, 2014New chief executive William J. Grubbs becomes CEO17
  15. Dec 18, 2006New chief executive Joseph Boshart becomes CEO18
  16. May 20, 1999Founded CROSS COUNTRY HEALTHCARE INC is founded2

Calendar

When it reported results

  1. May 7, 2026Reported quarterly or annual results78
  2. Mar 4, 2026Reported quarterly or annual results83
  3. Nov 12, 2025Reported quarterly or annual results85
  4. Aug 6, 2025Reported quarterly or annual results86
  5. May 7, 2025Reported quarterly or annual results87
  6. Mar 5, 2025Reported quarterly or annual results88
  7. Nov 6, 2024Reported quarterly or annual results89
  8. Jul 31, 2024Reported quarterly or annual results90

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

385 filings to the SEC since October 2021: 6 annual reports, 14 quarterly reports, 94 major events, 175 insider forms, 40 large holders, 2 private raises, 54 other. The latest 20:

  1. Jul 31, 202615-12G/A EDGAR
  2. Jul 28, 20268-K EDGAR
  3. Jul 27, 202615-12G EDGAR
  4. Jul 21, 202625-NSE EDGAR
  5. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  6. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  7. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  8. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  9. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  10. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  11. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  12. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  13. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  14. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  15. Jul 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  16. Jul 21, 2026S-8 POS EDGAR
  17. Jul 21, 2026S-8 POS EDGAR
  18. Jul 21, 2026S-8 POS EDGAR
  19. Jul 21, 2026S-8 POS EDGAR
  20. Jul 21, 2026S-8 POS EDGAR

The 385 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

25 open-market trades by officers, directors and large owners since October 2021: 3 buys and 22 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 11, 2026McDonald Colin PatrickChief Human Resources OfficerSale6,200$9.70$60.1KForm 4
Dec 9, 2025CASH W LARRYDirectorBuy5,000$8.17$40.8KForm 4
Aug 2, 2024Grieco Cynthia AnnVP, Corporate TreasurerSale1,945$17.21$33.5KForm 4
Aug 2, 2024Mote KarenPres., Cross Country LocumsSale13,829$17.08$236.2KForm 4
May 30, 2024Krug Marc S.Group President, DeliverySale13,657$14.82$202.4KForm 4
May 23, 2024Noe Phillip LynChief Information OfficerSale9,646$14.19$136.9KForm 4
Mar 15, 2024Mote KarenPres., Cross Country LocumsSale6,216$16.95$105.4KForm 4
Feb 23, 2024McDonald Colin PatrickChief Human Resources OfficerSale4,000$17.12$68.5KForm 4
Nov 28, 2023Grieco Cynthia AnnVP, Corporate TreasurerSale1,000$20.70$20.7KForm 4
Nov 22, 2023Ball Susan EGeneral Counsel and SecretarySale9,559$21.01$200.8KForm 4
Nov 21, 2023Burns William J.Chief Financial OfficerSale15,000$21.39$320.9KForm 4
Nov 21, 2023Ball Susan EGeneral Counsel and SecretarySale5,441$21.57$117.4KForm 4
Nov 21, 2023Redd James V. IIIChief Accounting OfficerSale6,843$21.54$147.4KForm 4
Nov 3, 2023Krug Marc S.Group President, DeliverySale6,000$19.91$119.5KForm 4
Nov 3, 2023Grieco Cynthia AnnVP, Corporate TreasurerSale6,370$20.60$131.2KForm 4
Feb 24, 2023McDonald Colin PatrickChief Human Resources OfficerSale9,000$25.60$230.4KForm 4
Nov 28, 2022Grieco Cynthia AnnVP, Corporate TreasurerSale1,071$36.00$38.6KForm 4
Oct 3, 2022Burns William J.Chief Financial OfficerSale40,293$30.91$1.2MForm 4
Oct 3, 2022Ball Susan EGeneral Counsel and SecretarySale14,901$30.00$447.0KForm 4
Sep 19, 2022Burns William J.Chief Financial OfficerSale14,705$28.99$426.2KForm 4

All 25 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Kevin C. ClarkPresident and Chief Executive Officer65$18.3K$2.4M105
2025William J. Burns, EVPChief Financial Officer$550.0K$1.3M105
2025Susan E. Ball, EVPChief Administrative Officer, General Counsel and Secretary$500.0K$1.1M105
2025John A. MartinsFormer President and Chief Executive Officer$888.5K105
2025Marc KrugGroup President$450.0K$858.8K105
2025Phillip L. NoeChief Information Officer$411.9K$614.5K105
2024John A. MartinsFormer President and Chief Executive Officer$875.0K$3.5M105
2024William J. Burns, EVPChief Financial Officer$550.2K$1.5M105
2024Susan E. Ball, EVPChief Administrative Officer, General Counsel and Secretary$500.0K$1.2M105
2024Marc KrugGroup President$450.0K$966.2K105
2024Phillip L. NoeChief Information Officer$411.9K$679.1K105
2023John A. MartinsFormer President and Chief Executive Officer$869.2K$3.5M105
2023William J. Burns, EVPChief Financial Officer$550.0K$1.5M105
2023Susan E. Ball, EVPChief Administrative Officer, General Counsel and Secretary$500.0K$1.2M105
2023Marc KrugGroup President$449.2K$953.3K105

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$6.5M 2021–2021
Money received by yearMoney received by year, 2021–2021: $6.5M in all. Private raises (Form D) $6.5M.$0$2M$4M$6M$8M2021 · Private raises (Form D): $6.5M2021
Figures by year
YearPrivate raises (Form D)Total
2021$6.5M$6.5M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Dec 16, 2021Raised $1.5 million in a private offering of equity106 Form D: 1 investor so far Form D
  2. Jun 8, 2021Raised $5 million in a private offering of equity72 Form D: 1 investor so far Form D

SEC filer profile

How CROSS COUNTRY HEALTHCARE INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCROSS COUNTRY HEALTHCARE INC1
  • CIK0001141103
  • Employer ID (EIN)13-40662295
  • Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company5
  • Incorporated inDelaware5
  • Fiscal year endsDecember 311
  • Industry code (SIC)7363 Services-Help Supply Services1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business address5201 Congress Avenue, Suite 160, Boca Raton, FL1
  • Phone80034722641
  • Shares outstanding32,332,661 as of Apr 24, 202613
  • Public float$393.1M as of Jun 30, 20255
  • AuditorDeloitte & Touche LLP, Boca Raton, Florida PCAOB ID 34; it also attests to the company’s internal control over financial reporting5
  • On EDGAR sinceJul 11, 20011
  • Filings1,777 in all: 4 (770), 8-K (457), SC 13G/A (132), 10-Q (74), 3 (53), SC 13G (50), DEFA14A (29), 4/A (28)1
    All 47 form types

    10-K (25), DEF 14A (25), ARS (14), UPLOAD (13), CORRESP (10), SCHEDULE 13G/A (9), 8-K/A (8), S-8 (7), S-8 POS (7), S-1/A (6), 10-K/A (4), 144 (4), 5 (4), SCHEDULE 13D/A (4), 3/A (3), DEFR14A (3), EFFECT (3), S-1 (3), SC 13D/A (3), SCHEDULE 13G (3), 10-Q/A (2), 424B2 (2), D (2), DEFM14A (2), PREM14A (2), S-3 (2), SC 13D (2), 15-12G (1), 15-12G/A (1), 25-NSE (1), 424B1 (1), 424B3 (1), 424B4 (1), 425 (1), 8-A12G (1), POS AM (1), PRE 14A (1), S-3/A (1), SCHEDULE 13D (1)

  • Latest filingsAnnual report (10-K) Mar 9, 2026
    Quarterly report (10-Q) May 8, 2026
    Proxy statement (DEF 14A) Mar 30, 2026
    Latest 8-K (8-K) Jul 28, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $0.0001 per shareCCRNThe Nasdaq Stock Market LLC

From the cover page of the 10-K filed Mar 9, 2026 (Section 12(b) of the Exchange Act).5

Risk factors and legal proceedings

The risks CROSS COUNTRY HEALTHCARE INC names in Item 1A of its 10-K filed Mar 9, 2026: 33 risks under these headings, as written.5

  • Business, Economic, and Industry Risks
  • Our operations and financial results may be affected by pandemics, epidemics, or other public health crises.
  • Global economic conditions and the effect of economic pressures could lead to decreases in demand or pricing for our services, which would adversely affect the profitability of our business.
  • We may face challenges competing in the marketplace if we are unable to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, customer needs, and capabilities.
  • Market disruptions or downturns may adversely affect our, or our customer’s, operating results and financial condition.
  • We are subject to business and regulatory risks associated with international operations.
  • Our financial results could be adversely impacted by the loss of key management or corporate employee turnover.
  • Our customers may terminate or not renew their contracts with us.
  • If our healthcare facility customers increase the use of intermediary organizations, it could impact our profitability and our ability to secure contracts with customers.
  • Our costs of providing services may rise faster than we are able to adjust our bill rates and pay rates and, as a result, our margins could decline and our profitability could be adversely impacted.
  • Operational Risks
  • We are dependent on the proper functioning of the information systems and technology applications used to operate our business, including applications hosted by third‑party vendors.
The other 23 risks
  • Company and third-party computer, technology and communications hardware and software systems are vulnerable to damage, unauthorized access, and disruption that could expose the Company to material operational, financial, and reputational damage (including the unauthorized access to, or exposure of, personal and confidential information).
  • Changes in data privacy and protection laws and regulations in respect of control of personal information (and the failure to comply with such laws and regulations) could increase the Company’s costs or otherwise adversely impact its operations, financial results, and reputation.
  • Social, ethical, and security issues relating to the use of AI may result in reputational harm and liability.
  • We may be unable to recruit and retain enough quality professionals to meet our customers’ demands.
  • Our labor costs could be adversely affected by a shortage of experienced healthcare professionals and labor union activity.
  • We are dependent on third parties for the execution of certain critical functions.
  • As the use of social media platforms expands, new risks and challenges may cause damage to our brand and reputation.
  • Our failure to protect our reputation could have a material adverse effect on our business.
  • Legal, Tax, and Regulatory Risks
  • The healthcare industry is highly regulated. Any material changes in the political, economic, or regulatory environment that affect the purchasing policies, practices, and operations of healthcare organizations, or that lead to consolidation in the healthcare industry, could reduce the funds available to purchase our services or otherwise require us to modify our offerings.
  • We operate our business in a regulated industry and modifications, inaccurate interpretations, or violations of any applicable statutory or regulatory requirements may result in material costs or penalties, as well as litigation, and could reduce our revenue and earnings per share.
  • We are subject to various litigation, claims, investigations, and other proceedings which could result in substantial judgments, settlement costs, or uninsured liabilities.
  • If applicable government regulations change, we may face increased costs that reduce our revenue and profitability.
  • We could suffer adverse tax and other financial consequences if taxing authorities do not agree with our tax positions, if there are further legislative tax changes, or if we are unable to utilize our net operating losses (NOLs).
  • If certain of our healthcare professionals are reclassified from independent contractors to employees, our profitability could be materially adversely impacted.
  • If the method for paying locum tenens physicians changes, it could negatively impact our profitability.
  • Risks Relating to Our Indebtedness
  • We could have a level of indebtedness which may have an adverse effect on our business or limit our ability to take advantage of business, strategic, or financing opportunities.
  • We could fail to generate sufficient cash to fund our liquidity needs and/or fail to satisfy the financial and other covenants to which we are subject under our existing indebtedness, which could adversely affect long term growth and results of operations.
  • General Business Risks
  • We continually evaluate opportunities to acquire companies or enter into other strategic transactions which may involve significant cash expenditures and expose us to unforeseen liabilities and/or integration challenges.
  • Notwithstanding the due diligence investigation we perform in connection with acquisitions, the acquired business may have liabilities, losses, or other exposures for which we do not have adequate insurance coverage, indemnification, or other protection.
  • Losses caused by natural disasters, such as hurricanes and fires, or other unexpected events, could cause us to suffer material financial losses.
  • Due to inherent limitations, our system of disclosure and internal controls and procedures may not be successful in preventing all errors and fraud, or in making all material information known in a timely manner to management.
  • Impairment in the value of our goodwill, trade names, or other intangible assets could negatively impact our net income and earnings per share.
  • If provisions in our corporate documents and Delaware law delay or prevent a change in control, we may be unable to consummate a transaction that our stockholders consider favorable.

Legal proceedings

Information with respect to certain legal proceedings is included in Note 12 - Contingencies to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data and is incorporated herein by reference.

The opening of Item 3, Legal Proceedings.5

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
    SEC EDGAROther events
  76. 76
    SEC EDGAROther events
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
  103. 103
  104. 104
  105. 105
  106. 106